Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis
- Resource Type
- Article
- Authors
- Planchard, David; Besse, Benjamin; Groen, Harry J.M.; Hashemi, Sayed M.S.; Mazieres, Julien; Kim, Tae Min; Quoix, Elisabeth; Souquet, Pierre-Jean; Barlesi, Fabrice; Baik, Christina; Villaruz, Liza C.; Kelly, Ronan J.; Zhang, Shirong; Tan, Monique; Gasal, Eduard; Santarpia, Libero; Johnson, Bruce E.
- Source
- In Journal of Thoracic Oncology January 2022 17(1):103-115
- Subject
- Language
- ISSN
- 1556-0864